Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: Lixisenatide evidence and protocol review
Also known as: Adlyxin
Lixisenatide is a once-daily GLP-1 receptor agonist approved by the FDA as Adlyxin for type 2 diabetes. As a shorter-acting agent dosed once daily before the first meal, it is studied primarily for its postprandial glucose-lowering effect via delayed gastric emptying, distinguishing it from longer-acting weekly agents in the same class.
Source review pending. This descriptive profile is shown from the available source material as a best-effort educational reference. It has not passed the full verification bar and is not a dosing instruction, medical claim, or treatment recommendation.
Data source: Primary literature, regulator records, trial registries, and identity-specific evidence search
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Amounts and schedules are separated by administration route. Evidence badges distinguish labels, human studies, preclinical work, community reports, and evidence gaps.
Days 1-14: 10 mcg once daily; day 15 onward: 20 mcg once daily
Context: ADLYXIN prescribing information
Formulation: Route-specific sterile formulation and professional handling requirements apply; concentration cannot be inferred from an oral or topical product.
Route safety: Use only in the cited label or guideline context; route, formulation, indication, and patient-specific limits still apply.
Do not convert an amount between routes. Bioavailability, formulation, sterility, monitoring, and clinical context differ by route. Research-use context only; independently verify every cited source.
The label-defined pen dose is more informative than a 300 mcg total alone. U.S. product availability should be checked separately from labeling history.
Supplementary research context only. Not medical advice or a treatment recommendation.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Published articles on this site that mention Lixisenatide or one of its catalog aliases.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.